Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
Department of Biostatistics and Bioinformatics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
Endokrynol Pol. 2022;73(2):316-324. doi: 10.5603/EP.a2022.0027.
Although the role of the thyroid ultrasound is well established in the initial thyroid nodule work up, it is still equivocal whether the thyroid ultrasound pattern could have an impact on refining malignancy risk after an indeterminate cytopathology result. We aim to assess the possible supportive role of the thyroid nodule ultrasound malignancy risk features listed in the Polish guidelines when a biopsy result is indeterminate.
We retrospectively reviewed thyroid ultrasound scans from 175 adult patients with thyroid nodules and indeterminate cytopathology results, who underwent thyroid surgery. Sonographic malignancy risk features were reported in accordance with the guidelines of the Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma and included the following: solid structure, hypoechogenicity, microcalcifications, taller than wide shape, irregular margins, features of extrathyroidal expansion, suspicious cervical lymph nodes.
The malignancy risk in relevant cytological categories, estimated on the basis of histological verification, was 10.9% for Bethesda III category, 12.1% for Bethesda IV, and 71.4% for Bethesda V. The predominant type of thyroid malignancy was papillary thyroid carcinoma (79%). Thyroid nodules sonographic malignancy risk features provided high specificity but low sensitivity in selected groups of indeterminate thyroid nodules. Microcalcifications was the only characteristic that solely had a clinically relevant positive likelihood ratio (> 10) to suggest malignancy in the analysed cohort, but it was not observed in thyroid nodules eventually verified as follicular thyroid carcinoma. An accumulation of more than one sonographic risk feature yielded significant increase in malignancy risk only in Bethesda V category thyroid nodules.
The impact of sonographic malignancy risk features on refining post-biopsy probability of thyroid cancer in thyroid nodule with indeterminate cytopathology, may be inadequate to sort patients (without any doubt) between those who require thyroid surgery and those who only require surveillance. There is an urgent need to search for new tools in the diagnostics of indeterminate thyroid nodules and to standardize thyroid ultrasound reports.
尽管甲状腺超声在初始甲状腺结节检查中具有重要作用,但在不确定的细胞学结果后,甲状腺超声模式是否能影响恶性肿瘤风险的评估仍存在争议。我们旨在评估在活检结果不确定的情况下,波兰指南中列出的甲状腺结节超声恶性风险特征是否具有支持作用。
我们回顾性分析了 175 例甲状腺结节和不确定细胞学结果的成年患者的甲状腺超声扫描结果,这些患者接受了甲状腺手术。超声恶性风险特征按照波兰国家诊断和治疗甲状腺癌协会的指南进行报告,包括以下内容:实性结构、低回声、微钙化、高宽比、不规则边缘、甲状腺外扩展特征、可疑颈部淋巴结。
基于组织学验证,在相关细胞学分类中,恶性风险估计为 Bethesda III 类为 10.9%,Bethesda IV 类为 12.1%,Bethesda V 类为 71.4%。主要的甲状腺恶性肿瘤类型是乳头状甲状腺癌(79%)。在选定的不确定甲状腺结节组中,甲状腺结节超声恶性风险特征具有较高的特异性,但敏感性较低。微钙化是唯一一种在分析队列中具有临床相关阳性似然比(>10)提示恶性肿瘤的特征,但在最终证实为滤泡性甲状腺癌的甲状腺结节中并未观察到。只有在 Bethesda V 类甲状腺结节中,多个超声风险特征的累积才会显著增加恶性风险。
在不确定的甲状腺细胞学结节中,超声恶性风险特征对细化甲状腺癌活检后概率的影响可能不足以将需要甲状腺手术的患者(毫无疑问)与仅需要监测的患者区分开来。迫切需要在不确定的甲状腺结节的诊断中寻找新的工具,并标准化甲状腺超声报告。